Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2014 10:39 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, MANITOBA--(Marketwired - June 26, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that it has issued 149,517 common shares of the Corporation...
June 18, 2014 11:24 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Grant of Options

WINNIPEG, MANITOBA--(Marketwired - June 18, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
June 05, 2014 11:42 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Board Members

WINNIPEG, MANITOBA--(Marketwired - June 5, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
April 02, 2014 11:12 ET | Source: Kane Biotech Inc.

Kane Biotech Appoints Dr. Sarah Prichard, M.D. to the Board of Directors

WINNIPEG, MANITOBA--(Marketwired - April 2, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company developing and commercializing products that prevent and remove microbial...
April 01, 2014 15:41 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, MANITOBA--(Marketwired - April 1, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that it has issued 118,383 common shares of the Corporation...
March 26, 2014 10:30 ET | Source: Kane Biotech Inc.

StrixNB(TM) Powder Formulation Approved by Health Canada's LRVHP Program

WINNIPEG, MANITOBA--(Marketwired - March 26, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...
March 11, 2014 08:00 ET | Source: Kane Biotech Inc.

StrixNB(TM) Effective Against Cat Bite Wound Infections

WINNIPEG, MANITOBA--(Marketwired - March 11, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
February 04, 2014 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives $397,500 From Warrant Exercise

WINNIPEG, MANITOBA--(Marketwired - Feb. 4, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
January 07, 2014 08:00 ET | Source: Kane Biotech Inc.

DispersinB(R) Topical Spray Approval from Health Canada's LRVHP Program

WINNIPEG, MANITOBA--(Marketwired - Jan. 7, 2014) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
December 18, 2013 17:57 ET | Source: Kane Biotech Inc.

Kane Biotech Announces Closing of Private Placement Offering

WINNIPEG, MANITOBA--(Marketwired - Dec. 18, 2013) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") today announced that the Corporation has closed its previously announced...